Laporan Laba Rugi 002907 - TTM - Chongqing Pharscin Pharmaceutical Co., Ltd.

Laporan Laba Rugi (TTM)

Laporan Laba Rugi Chongqing Pharscin Pharmaceutical Co., Ltd. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

	2020 09-30	2020 12-31	2021 03-31	2021 06-30	2021 09-30	2022 01-01	2022 03-31	2022 06-30	2022 09-30	2023 03-31	2023 06-30	2023 09-30	2024 03-31	2024 06-30	2024 09-30	2024 12-31	2025 03-31	2025 06-30
Revenue	840	882	942	939	903	846	819	778	762	770	778	739	732	749	791	775	785	799
Change (%)		5.00	6.74	-0.34	-3.82	-6.28	-3.19	-5.02	-2.00	0.95	1.08	-5.05	-0.86	2.26	5.55	-1.98	1.36	1.72
% of Revenue	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00

Cost Of Sales	392	459	501	488	449	401	379	351	334	305	319	312	328	334	350	333	341	339
Change (%)		17.05	9.22	-2.70	-8.02	-10.71	-5.50	-7.31	-4.84	-8.60	4.38	-2.02	5.05	1.86	4.70	-4.79	2.28	-0.40
% of Revenue	46.65	52.00	53.21	51.95	49.68	47.34	46.21	45.10	43.79	39.65	40.94	42.24	44.76	44.59	44.23	42.97	43.36	42.45

Gross Operating Profit	448	424	441	451	454	446	441	427	429	465	459	427	405	415	441	442	445	460
Change (%)		-5.53	4.05	2.34	0.72	-1.92	-1.12	-3.05	0.33	8.39	-1.10	-7.14	-5.18	2.58	6.23	0.24	0.67	3.35
% of Revenue	53.35	48.00	46.79	48.05	50.32	52.66	53.79	54.90	56.21	60.35	59.06	57.76	55.24	55.41	55.77	57.03	56.64	57.55

SG&A	282	268	273	282	284	297	297	287	293	294	301	283	282	293	310	310	310	313
Change (%)		-4.75	1.75	3.29	0.66	4.81	-0.12	-3.42	2.12	0.45	2.22	-5.79	-0.59	4.01	5.81	-0.07	-0.03	0.94
% of Revenue	33.50	30.39	28.97	30.02	31.42	35.14	36.26	36.87	38.42	38.23	38.66	38.36	38.46	39.12	39.21	39.98	39.43	39.13

R&D	33	36	38	40	39	42	44	46	55	64	67	69	77	75	68	59	59	70
Change (%)		11.38	4.78	4.87	-2.94	7.25	5.57	4.09	20.54	15.88	3.86	4.23	10.52	-2.04	-9.79	-12.67	-0.57	19.63
% of Revenue	3.90	4.13	4.06	4.27	4.31	4.93	5.38	5.89	7.25	8.32	8.55	9.38	10.46	10.02	8.56	7.63	7.49	8.80

OpEx	722	773	822	836	799	751	731	687	685	676	703	681	694	711	738	712	724	741
Change (%)		7.18	6.33	1.69	-4.47	-5.97	-2.70	-6.06	-0.26	-1.35	4.01	-3.07	1.85	2.52	3.76	-3.46	1.57	2.34
% of Revenue	85.85	87.63	87.30	89.08	88.48	88.78	89.23	88.26	89.82	87.78	90.33	92.20	94.73	94.97	93.36	91.95	92.14	92.70

Operating Income	119	109	120	102	104	95	88	91	78	94	75	58	39	38	52	62	62	58
Change (%)		-8.22	9.62	-14.32	1.47	-8.70	-7.10	3.59	-15.06	21.20	-20.01	-23.47	-32.95	-2.35	39.23	18.79	-1.07	-5.52
% of Revenue	14.15	12.37	12.70	10.92	11.52	11.22	10.77	11.74	10.18	12.22	9.67	7.80	5.27	5.03	6.64	8.05	7.86	7.30

Interest Expense	-17	-17	-18	-18	-18	-18	-18	-19	-19	-10	-6	-1	-1	-0	-0		-0	-0
Change (%)		2.05	2.05	1.08	1.32	1.33	1.22	1.68	1.52	-48.21	-43.82	-82.77	-18.74	-59.80	-89.49			3,023.29
% of Revenue	-2.01	-1.95	-1.86	-1.89	-1.99	-2.15	-2.25	-2.41	-2.50	-1.28	-0.71	-0.13	-0.11	-0.04	-0.00		-0.00	-0.01

Net Income	127	119	128	113	114	92	85	87	75	99	88	70	43	39	63	77	77	83
Change (%)		-5.98	7.24	-11.88	1.08	-19.38	-7.76	3.34	-14.05	31.86	-11.46	-19.89	-38.93	-10.24	62.12	22.77	0.01	8.77
% of Revenue	15.08	13.51	13.57	12.00	12.61	10.85	10.34	11.24	9.86	12.88	11.28	9.52	5.86	5.15	7.91	9.90	9.77	10.45

Source: Capital IQ

Chongqing Pharscin Pharmaceutical Co., Ltd. - Laporan Laba Rugi (TTM)

Laporan Laba Rugi (TTM)